Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Multi-domain Assessment and Quality of Life in Patients Older Than 60 Years Receiving an Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Patients older than 60 years are more and more transplanted. Comprehensive geriatric assessment (CGA) have been developed and are currently used in patients with cancer, it has been correlated with the prognosis. There is still few data in transplanted patients and the aim of this study is to assess these patients before and after transplantation in order to monitor their general health and quality of life (QOF) and correlate them to the prognostic.

Inclusion Criteria:

• 60 years or more at time of transplantation
• Patient receiving a hematopoietic stem cell allograft for myeloid hemopathy (myeloid acute leukemia, myelodysplastic syndrome, Myeloproliferative neoplasm) or for an Acute lymphoblastic leukemia
• No opposition to participate

Exclusion Criteria:

• Patient opposed to the protocol
• Vulnerable patients protected by curatorship or administrative supervision
• Patients not covered by a social security scheme